|
|
Volumn 25, Issue 3, 2015, Pages 265-268
|
|
A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab
a,d
|
|
Author keywords
Adverse events; Bullous pemphigoid; Immune related; Metastatic melanoma; Pembrolizumab
|
|
Indexed keywords
BETAMETHASONE;
DACARBAZINE;
DEXAMETHASONE;
FOTEMUSTINE;
IPILIMUMAB;
PEMBROLIZUMAB;
PREDNISONE;
STEROID;
ANTIINFLAMMATORY AGENT;
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
PROGRAMMED DEATH 1 RECEPTOR;
ACANTHOSIS;
AGED;
ARTICLE;
BRAIN METASTASIS;
BRONCHITIS;
BULLOUS PEMPHIGOID;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER PATIENT;
CASE REPORT;
CHRONIC INFLAMMATION;
COMPUTER ASSISTED TOMOGRAPHY;
DERMATITIS;
DERMOEPIDERMAL JUNCTION;
DISEASE COURSE;
DRUG DOSE COMPARISON;
DRUG DOSE REDUCTION;
DRUG SUBSTITUTION;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
ECZEMA;
EOSINOPHIL;
EXOCYTOSIS;
FOLLOW UP;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOFLUORESCENCE MICROSCOPY;
LUNG BIOPSY;
LUNG LESION;
LUNG METASTASIS;
LYMPHOCYTE;
MALE;
MALIGNANT LENTIGO;
METASTATIC MELANOMA;
MULTIPLE CYCLE TREATMENT;
MULTIPLE PULMONARY NODULES;
PARAKERATOSIS;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SINGLE DRUG DOSE;
SKIN BIOPSY;
SKIN EXAMINATION;
SKIN PRURITUS;
THORAX RADIOGRAPHY;
ANTAGONISTS AND INHIBITORS;
CHEMICALLY INDUCED;
DIFFERENTIAL DIAGNOSIS;
DRUG ERUPTIONS;
DRUG MONITORING;
FATALITY;
MELANOMA;
METABOLISM;
PEMPHIGOID, BULLOUS;
SECONDARY;
AGED;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
DEXAMETHASONE;
DIAGNOSIS, DIFFERENTIAL;
DRUG ERUPTIONS;
DRUG MONITORING;
FATAL OUTCOME;
HUMANS;
MALE;
MELANOMA;
PEMPHIGOID, BULLOUS;
PREDNISONE;
PROGRAMMED CELL DEATH 1 RECEPTOR;
|
|
EID: 84929627231
PISSN: 09608931
EISSN: 14735636
Source Type: Journal
DOI: 10.1097/CMR.0000000000000155 Document Type: Article |
|
Times cited : (106)
|
|
References (8)
|
